Professor Tim Witney
Professor of Molecular Imaging
- Wellcome Trust Senior Research Fellow
Research interests
- Imaging sciences
Biography
Dr Tim Witney is a Wellcome Trust Senior Research Fellow and Professor of Molecular Imaging in the School of Biomedical Engineering & Imaging Sciences.
The aim of the Witney Lab is to design and develop new positron emission tomography (PET) methods to image tumour biochemistry in vivo. Using a multidisciplinary approach, the group focuses on how these novel molecular imaging techniques can be used to non-invasively predict tumour response and resistance to treatment, with a view to translating these methods into the clinic. The identification of cancer patients that are refractory to the standard of care will allow the selection of alternative therapies that have the potential to improve patient response and survival.
News
In Conversation with Professor Tim Witney
Prof Tim Witney on his entrepreneurship journey and the launch of King's biotech spinout Nuclide Therapeutics.
King's spin-out Nuclide Therapeutics secures £5 million investment
£5 million investment in King's biotech spin-out to identify and target therapy-resistant cancers.
King's researchers make splash at CRH Innovation and Entrepreneurship Awards 2025
A wide cohort of researchers from King’s have been shortlisted for the Cancer Research Horizons Innovation and Entrepreneurship Awards 2025, shining a...
Groundbreaking Cancer Imaging Trial Begins Using Advanced PET Scanner
A pioneering clinical trial has begun to evaluate a new imaging tracer that could revolutionise cancer treatment monitoring.
Professor Tim Witney elected Vice President of ESMI
Professor Tim Witney, Wellcome Trust Senior Research Fellow and Professor of Molecular Imaging at the School of Biomedical Engineering & Imaging Sciences, has...
Scientists develop new scans that light-up aggressive cancer tumours for better treatment
Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that could help medical professionals...
Chicken eggs could provide low-cost opportunities for cancer imaging research
King’s researchers have identified how fertilised chicken eggs could function as a viable option for cancer imaging studies and radiotracer development.
New review explores use of novel radiotracer in cancer imaging
Researchers from the School of Biomedical Engineering & Imaging Sciences have published a new review examining the suitability of a novel radiotracer in...
£650,000 awarded to develop novel imaging, AI-methods, and targeted treatment for therapy-resistant lung cancer
Researchers from King’s College London, The University of Oxford, Newcastle University, and The University of Cambridge have received funding to develop an...
Dr. Tim Witney appointed Editor-in-Chief of new imaging journal
King’s researcher Dr. Tim Witney, has been appointed Editor-in-Chief of npj Imaging, a new imaging journal from Nature publishing group.
Events
Inaugural Lectures: Professors Tim Witney & Anna Goodman
Inspiring talks from two of our new professors about their work, their specialisations, and their journeys to where they are today.
Please note: this event has passed.
Features
A researcher's perspective on experiencing cancer
Professor Witney has spent his career developing technologies to better detect and treat cancer. In 2023, however, his professional expertise was tested in a...
News
In Conversation with Professor Tim Witney
Prof Tim Witney on his entrepreneurship journey and the launch of King's biotech spinout Nuclide Therapeutics.
King's spin-out Nuclide Therapeutics secures £5 million investment
£5 million investment in King's biotech spin-out to identify and target therapy-resistant cancers.
King's researchers make splash at CRH Innovation and Entrepreneurship Awards 2025
A wide cohort of researchers from King’s have been shortlisted for the Cancer Research Horizons Innovation and Entrepreneurship Awards 2025, shining a...
Groundbreaking Cancer Imaging Trial Begins Using Advanced PET Scanner
A pioneering clinical trial has begun to evaluate a new imaging tracer that could revolutionise cancer treatment monitoring.
Professor Tim Witney elected Vice President of ESMI
Professor Tim Witney, Wellcome Trust Senior Research Fellow and Professor of Molecular Imaging at the School of Biomedical Engineering & Imaging Sciences, has...
Scientists develop new scans that light-up aggressive cancer tumours for better treatment
Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that could help medical professionals...
Chicken eggs could provide low-cost opportunities for cancer imaging research
King’s researchers have identified how fertilised chicken eggs could function as a viable option for cancer imaging studies and radiotracer development.
New review explores use of novel radiotracer in cancer imaging
Researchers from the School of Biomedical Engineering & Imaging Sciences have published a new review examining the suitability of a novel radiotracer in...
£650,000 awarded to develop novel imaging, AI-methods, and targeted treatment for therapy-resistant lung cancer
Researchers from King’s College London, The University of Oxford, Newcastle University, and The University of Cambridge have received funding to develop an...
Dr. Tim Witney appointed Editor-in-Chief of new imaging journal
King’s researcher Dr. Tim Witney, has been appointed Editor-in-Chief of npj Imaging, a new imaging journal from Nature publishing group.
Events
Inaugural Lectures: Professors Tim Witney & Anna Goodman
Inspiring talks from two of our new professors about their work, their specialisations, and their journeys to where they are today.
Please note: this event has passed.
Features
A researcher's perspective on experiencing cancer
Professor Witney has spent his career developing technologies to better detect and treat cancer. In 2023, however, his professional expertise was tested in a...